Dr. Marcus Chuan Beng Tan, MD

Dr. Tan practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Tan's NPI, 1467518266, was assigned on December 28, 2006. Dr. Tan holds Tennessee license MD0000056704.

Dr. Tan's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Tan's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Tan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tan practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Tan's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Tan's licenses on file in 3 states: Tennessee, Alabama and Missouri.

CMS data shows 183 Medicare services from Dr. Tan across 8 procedure codes in 2024, for 136 Medicare patients. Medicare paid $13,419 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Tan in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tan's median patient age at 70, with 45% women.

In 2024, Dr. Tan wrote 79 Medicare Part D claims for 26 patients. 47% of them were for generic drugs. CMS names the drug for 37 of them, across 1 drug with 11 or more claims each, at $115,701 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

Dr. Tan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tan as offering telehealth.

Dmand AI links 10 papers to Dr. Tan, published from 2015 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Pancreatic Neoplasms, Biomarkers, Tumor and Carcinoma, Pancreatic Ductal. Dr. Tan has published most often in Am Surg. Dr. Tan's most frequent co-authors are Peter J. Allen, MD, Christina Edwards Bailey, MD and Olca Basturk, MD.

Dmand AI links Dr. Tan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases.

CMS Open Payments shows 50 general payments to Dr. Tan from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 44% of the total. Intuitive Surgical, Inc. paid the most, $7,377.